Today we use antibiotics for many diseases. This increases microbes' antibiotic resistance and makes medicines ineffective. Scientists are investigating whether CBD could offer a solution.
According to an experiment by Australian research company Botanix Pharmaceuticals, CBD could eliminate Gram-negative bacteria, a type resistant to antibiotics.
Lead researcher Dr. Mark Blaskovich of the University of Queensland reported that CBD had demonstrated human safety and that he believed its anti-inflammatory properties could be valuable for future antibiotic research.
Insights from the research
In experiments, Dr. Blaskovich and his team found CBD effective at killing multiple Gram-negative bacteria, including Staphylococcus aureus, Streptococcus pneumoniae and even MRSA, known for antibiotic resistance.
Researchers also reported that bacteria failed to develop CBD resistance even after 21 days, a period in which most antibiotics fall short.
According to the research, CBD succeeded where nearly every antibiotic failed and could disrupt the protective bacterial layer known as a biofilm.
CBD's future against super-virus infections
Although promising, these findings require more research to establish CBD's effectiveness against Gram-negative bacteria outside the laboratory.
If Blaskovich's team's findings can be replicated and refined outside laboratory conditions, CBD could provide a powerful solution to future super-virus infections.
“The results and potential applications of this extraordinary research are enormous,” said Botanix founder and director Matt Callahan. Botanix said it wanted to move on to clinical trials.
